CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?

J Am Coll Cardiol. 2016 Mar 1;67(8):948-950. doi: 10.1016/j.jacc.2016.01.002.
No abstract available

Keywords: acute coronary syndrome; dual antiplatelet therapy; genetics; platelets.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Cytochrome P-450 CYP2C19 / genetics*
  • DNA / genetics*
  • Female
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Prasugrel Hydrochloride / administration & dosage*
  • Ticlopidine / analogs & derivatives*

Substances

  • DNA
  • Cytochrome P-450 CYP2C19
  • Prasugrel Hydrochloride
  • Ticlopidine